Brain Tumor Genetic Modification Yields Increased Resistance to Paclitaxel in Physical Confinement

Loan Bui1, Alissa Hendricks1, Jamie Wright1

  • 1Department of Bioengineering, University of Texas at Arlington, TX, USA.

Scientific Reports
|May 18, 2016
PubMed

Insights

Confined environments impact brain tumor cell survival and drug resistance. Specific genetic changes, like PTEN loss and Braf activation, increase viability and Taxol resistance in narrow microchannels.

Area of Science:

  • Oncology
  • Biophysics
  • Cell Biology

Background:

  • Brain tumor cells exhibit significant resistance to conventional therapies.
  • Understanding cellular responses in microenvironments is crucial for developing new treatments.

Purpose of the Study:

  • To investigate the influence of microchannel confinement on brain cancer cell viability and drug resistance.
  • To identify genotype-specific drug targets and survival phenotypes.

Main Methods:

  • Utilized microchannel devices to culture and analyze various brain cancer cell lines and genetically modified mouse astrocytes.
  • Assessed cell viability and drug resistance (Taxol) under confined conditions.

Main Results:

  • Loss of PTEN combined with Braf activation enhanced cell viability in narrow microchannels.
  • Braf activation increased resistance to Taxol in confined environments.
  • D54-EGFRvIII cells showed Taxol resistance, unlike D54 cells which had 75% reduced viability.

Conclusions:

  • Cellular genotype and specific survival phenotypes in confined migration are key determinants for anticancer drug targeting.
  • Microchannel confinement influences drug resistance, suggesting novel therapeutic strategies.

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.3K